Earnest Partners LLC Decreases Stock Holdings in Agilent Technologies, Inc. $A

Earnest Partners LLC lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 2.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 475,937 shares of the medical research company’s stock after selling 11,310 shares during the quarter. Earnest Partners LLC’s holdings in Agilent Technologies were worth $61,087,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Brighton Jones LLC grew its position in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the period. Jones Financial Companies Lllp raised its position in shares of Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after purchasing an additional 769 shares during the last quarter. Geneos Wealth Management Inc. lifted its stake in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after buying an additional 212 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after buying an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in Agilent Technologies during the 2nd quarter worth approximately $273,000.

Analyst Ratings Changes

A number of brokerages have commented on A. Morgan Stanley reduced their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their price target for the stock from $155.00 to $160.00 in a research report on Monday, January 5th. Wells Fargo & Company reduced their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Bank of America raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Tuesday, November 25th. Finally, Barclays lowered their target price on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $161.20.

Agilent Technologies Price Performance

NYSE:A opened at $111.60 on Monday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The stock has a market cap of $31.54 billion, a PE ratio of 24.64, a P/E/G ratio of 2.35 and a beta of 1.31. The stock has a 50 day moving average price of $130.34 and a 200 day moving average price of $135.95.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s payout ratio is presently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.